| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/21/2005 | US20050086707 Nucleic acid and corresponding protein entitled 98P4B6 useful in treatment and detection of cancer |
| 04/21/2005 | US20050085894 High strength and lubricious materials for vascular grafts |
| 04/21/2005 | US20050085631 Process for decreasing aggregate levels of pegylated protein |
| 04/21/2005 | US20050085630 Photocleavable isotope-coded affinity tags |
| 04/21/2005 | US20050085629 Utilization of FPRL1 as a functional receptor by serum amyloid A (SAA) |
| 04/21/2005 | US20050085627 Nucleotide sequences coding histone methyltransferase for use in identifying modulators for treatment and prevention of asthma disorders |
| 04/21/2005 | US20050085626 Isolated binding pocket of serine/threonine kinase for use as tool in identifying modulator for prevention and treatment of celll proliferative disorders |
| 04/21/2005 | US20050085625 Trangenic membrane protein for use as tool in identifying modulators of taste; food processing |
| 04/21/2005 | US20050085622 Method for modifying protein or peptide C-terminal |
| 04/21/2005 | US20050085621 Asparagine in position B3 and lysine in position B29 are replaced by lysine and glutamic acid, respectively; inhalant and oral dosage forms; dissolving and purifying the amorphous powder; antidiabetic agents |
| 04/21/2005 | US20050085422 Peptides derived from colostrinin |
| 04/21/2005 | US20050085421 Derived from ghrelin polypeptide, labelled with fluorochrome and cysteine; drug screening; high throughput assay |
| 04/21/2005 | US20050085419 Anti-growth factor receptor avidin fusion proteins as universal vectors for drug delivery |
| 04/21/2005 | US20050085418 Ligands for TGF-beta binding proteins and uses thereof |
| 04/21/2005 | US20050085416 Stabilized albumin, fatty acid complex; anticancer agents; bactericides |
| 04/21/2005 | US20050085412 Hydrosilation of follicle stimulating hormone; efficiency |
| 04/21/2005 | US20050085411 A peptidomimetic as an antiproliferative agent |
| 04/21/2005 | US20050085410 Artificial oxygen carrier and production method thereof |
| 04/21/2005 | US20050084972 Plasmid for transfer and expression of antitrypsin gene sequences in sacchromyces; bioreactors |
| 04/21/2005 | US20050084969 Method for producing a recombinant polypeptide |
| 04/21/2005 | US20050084947 Recombinant RSV virus expression systems and vaccines |
| 04/21/2005 | US20050084937 Alpha-amylase mutants |
| 04/21/2005 | US20050084936 Human regulatory proteins |
| 04/21/2005 | US20050084935 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/21/2005 | US20050084933 Product quality enhancement in mammalian cell culture processes for protein production |
| 04/21/2005 | US20050084932 Binding assays that use the T1R1/T1R3 (Umami) taste receptor to identify compounds that elicit or modulate umami taste |
| 04/21/2005 | US20050084931 Human prostaglandin DP receptor variants and methods of using same |
| 04/21/2005 | US20050084929 Human prostaglandin EP4 receptor variants and methods of using same |
| 04/21/2005 | US20050084928 Transgenic cells comprising transfected glutamine synthetase gene for use as bioreactor in propagation of heterologous proteins |
| 04/21/2005 | US20050084927 Modified by immobilizing with disulfide-containing compound; mass spectrometry; solid phase synthesis |
| 04/21/2005 | US20050084926 Method for cell-free protein complete post-translational modification |
| 04/21/2005 | US20050084916 Identification of the IkappaBNS protein and its products |
| 04/21/2005 | US20050084913 Tumor antigen for use as tool in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy |
| 04/21/2005 | US20050084911 DNA molecules encoding imidazoline receptive polypeptides and polypeptides encoded thereby |
| 04/21/2005 | US20050084903 Lectin protein prepared from maackia fauriei, process for preparing the same and the use thereof |
| 04/21/2005 | US20050084902 Peptide-immobilized substrate and method for measuring target protein |
| 04/21/2005 | US20050084900 Mammalian cell membrane proteins; related reagents |
| 04/21/2005 | US20050084899 Compositions and methods relating to breast specific genes and proteins |
| 04/21/2005 | US20050084897 DNA encoding human vanilloid receptor VR3 |
| 04/21/2005 | US20050084885 Modified transcription factor protein for use as tool in prevention and treatment of cell proliferative disorder |
| 04/21/2005 | US20050084876 Flip genes and flip proteins |
| 04/21/2005 | US20050084873 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 04/21/2005 | US20050084871 Organic anion transporter genes and proteins |
| 04/21/2005 | US20050084868 Generation of stabilized proteins by combinatorial consensus mutagenesis |
| 04/21/2005 | US20050084859 Herbicide metabolizing proteins; ferredoxins; methylation, dehydrogenation; kits |
| 04/21/2005 | US20050084858 Method for monitoring and prognosis of disease course of gastrointestinal tumors |
| 04/21/2005 | US20050084857 Breast tumor antigen for use as tool in diagnosis prevention and treatment of mammary gland cell proliferative disorders; antitumor agents |
| 04/21/2005 | US20050084853 Nucleotide sequences coding actin binding protein for use as tool in identifying modulator for prevention and treatment of fungal infection; fungicides |
| 04/21/2005 | US20050084850 Stromal cell protein for use as tool in stimulating blood production in patients undergoing chemotherapy |
| 04/21/2005 | US20050084504 Methods for treating various disorders with a neurotoxic component of a botulinum toxin |
| 04/21/2005 | US20050084503 Continuous cell line for the production of vaccines |
| 04/21/2005 | US20050084499 Comprises polypeptides for use in serodiagnosis and treatment of chlamydial sexually transmitted disease; vaccines |
| 04/21/2005 | US20050084498 EBV CTL epitopes |
| 04/21/2005 | US20050084497 Immunogens; replication-defective; antibodies; host cells; kits |
| 04/21/2005 | US20050084496 Scytovirins and related conjugates, fusion proteins, nucleic acids, vectors, host cells, compositions, antibodies and methods of using scytovirins |
| 04/21/2005 | US20050084491 Use as an immunogen to generate anti-integrin antibodies; a mimotope; vaccinating against angiogenic and metastatic diseases |
| 04/21/2005 | US20050084487 Bone disorders, antiarthritic agents; immunizing transgenic knockout animals to obtain anti-WIF-1 antibodies |
| 04/21/2005 | DE10392358T5 Verfahren und System für die in Vivo-Analyse von Entwicklungsvorgängen A method and system for the in vivo analysis of developmental processes |
| 04/21/2005 | CA2761987A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2578473A1 Peptide nucleic acid conjugates and uses thereof |
| 04/21/2005 | CA2550583A1 Modified cea /b7 vector |
| 04/21/2005 | CA2546730A1 A method for the treatment of malignant diseases by inhibiting nucleolin |
| 04/21/2005 | CA2542860A1 Fluorescence indicator utilizing fret |
| 04/21/2005 | CA2542612A1 Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease |
| 04/21/2005 | CA2542608A1 Igf-i responsive gene and use thereof |
| 04/21/2005 | CA2542479A1 Sperm protective polypeptides and uses thereof |
| 04/21/2005 | CA2542353A1 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 04/21/2005 | CA2542288A1 Chimeric promoter comprising hcmv major immediate early gene exons and a heterologous intron |
| 04/21/2005 | CA2542179A1 Il-21 derivatives |
| 04/21/2005 | CA2542046A1 Fused protein composition |
| 04/21/2005 | CA2542035A1 Process for producing antithrombin iii composition |
| 04/21/2005 | CA2541804A1 Nucleic acid molecules and proteins for the identification, assessment, prevention, and therapy of ovarian cancer |
| 04/21/2005 | CA2541464A1 Piscirickettsia salmonis antigens and use thereof |
| 04/21/2005 | CA2541360A1 Methods and compositions for diagnosis and treatment of b cell chronic lymphocytic leukemia |
| 04/21/2005 | CA2540884A1 C-terminally truncated interferon alpha variants |
| 04/21/2005 | CA2540551A1 Single nucleotide polymorphism analysis of highly polymorphic target sequences |
| 04/21/2005 | CA2540199A1 Nucleotide sequences and polypeptides encoded thereby useful for producing transformed plants expressing lethal/nonviability genes |
| 04/21/2005 | CA2539681A1 Nucleic acid molecules encoding novel human low-voltage activated calcium channel proteins, designated - alpha 1i-1 and alpha 1i-2, encoded proteins and methods of use thereof |
| 04/21/2005 | CA2539068A1 Hiv vaccines based on env of multiple clades of hiv |
| 04/21/2005 | CA2538903A1 Isolated photoprotein mtclytin, and use thereof |
| 04/21/2005 | CA2537473A1 Cytokine involved in epithelial-mesenchymal transition |
| 04/21/2005 | CA2535982A1 Uses of interferons with altered spatial structure |
| 04/20/2005 | EP1524524A1 Methods for detection and use of differentially expressed OSF-2 in diagnosis of cardiac hypertrophy |
| 04/20/2005 | EP1524318A1 Genes and proteins for the biosynthesis of polyketides |
| 04/20/2005 | EP1524316A2 Method of determining propensity of bacteria for dissolved oxygen instability |
| 04/20/2005 | EP1524274A1 Fluorescently labelled Ghrelin peptides. |
| 04/20/2005 | EP1523999A1 High strength and lubricious materials using spider silk for vascular grafts |
| 04/20/2005 | EP1523992A1 Vaccine formulation against Gumboro disease |
| 04/20/2005 | EP1523582A2 Rapid, efiicient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 04/20/2005 | EP1523564A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 04/20/2005 | EP1523563A2 Modified adenoviral fiber with ablated to cellular receptors |
| 04/20/2005 | EP1523562A1 Expression receptors with 7 transmembrane domains in baculovirus- insect cell system |
| 04/20/2005 | EP1523560A2 Modulating developmental pathways in plants |
| 04/20/2005 | EP1523558A1 Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 04/20/2005 | EP1523557A2 Antigens encoded by alternative reading frame from pathogenic viruses |
| 04/20/2005 | EP1523555A2 Transgenic animal models of hrv with humani icam-1 sequences |
| 04/20/2005 | EP1523502A1 Serotonin receptor |
| 04/20/2005 | EP1523501A1 Inhibition of cell division based use of analogs of neuropeptide y |
| 04/20/2005 | EP1523500A1 Process for the purification of interleukin-4 and its muteins |
| 04/20/2005 | EP1523499A2 Fragments of beta-amyloid as targets for vaccination against alzheimer disease |